PolyPid (PYPD) Liabilities and Shareholders Equity (2019 - 2026)

PolyPid has reported Liabilities and Shareholders Equity for 8 years, with the latest figure at $19.2 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 13.72% year-over-year to $19.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $106.0 million (up 30.55% YoY) and the FY2025 annual result came in at $22.3 million, down 11.55% from the prior year.
• Liabilities and Shareholders Equity slipped to $19.2 million in Q1 2026 per PYPD's latest filing, from $22.3 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $37.7 million in Q2 2025 and troughed at $15.4 million in Q4 2023.
• A 5-year average of $25.4 million and a median of $25.4 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity plunged 49.2% in 2022, then surged 93.0% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $26.0 million in 2022, then tumbled by 40.81% to $15.4 million in 2023, then jumped by 64.06% to $25.2 million in 2024, then retreated by 11.55% to $22.3 million in 2025, then decreased by 14.11% to $19.2 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $19.2 million, $22.3 million, and $26.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.